The promise of macrophage-derived extracellular vesicles
Keywords:
Macrophages, extracellular vesicles, drug deliveryAbstract
In recent years the development of therapies has been impressive. Unfortunately, many of these therapies have presented some limitations, mainly in vivo. Consequently, efforts continue to design drug delivery systems that address these limitations, among which are macrophage-derived extracellular vesicles (MEVs). This is due to their natural characteristics, mainly their surface markers, which enable their function as messengers and their production methods accessible. These features have facilitated their use in developing therapies against cancer and inflammatory diseases, yielding promising results. Therefore, our objective is to highlight why MEVs are emerging as a promising drug delivery strategy.
References
Haney M. J., Zhao Y., Jin Y. S., Li S. M., Bago J. R., Klyachko N. L., Kabanov A. V., & Batrakova E. V. (2020). Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy. Journal of Neuroimmune Pharmacology, 15 (3), 487 500. https://doi.org/10.1007/s11481-019-09884-9
Liang T., Zhang R., Liu X., Ding Q., Wu S., Li C., Lin Y., Ye Y., Zhong Z., & Zhou M. (2021). Recent Advances in Macrophage-Mediated Drug Delivery Systems. International Journal of Nanomedicine, Volume 16 , 2703 2714. https://doi.org/10.2147/IJN.S298159
Wang Y., Zhao M., Liu S., Guo J., Lu Y., Cheng J., & Liu J. (2020). Macrophage-derived extracellular vesicles: diverse mediators of pathology and therapeutics in multiple diseases. Cell Death & Disease, 11 (10), 924. https://doi.org/10.1038/s41419-020-03127-z
Guo L., Zhang Y., Wei R., Zhang X., Wang C., & Feng M. (2020). Proinflammatory macrophage-derived microvesicles exhibit tumor tropism dependent on CCL2/CCR2 signaling axis and promote drug delivery via SNARE-mediated membrane fusion. Theranostics, 10 (15), 6581 6598. https://doi.org/10.7150/thno.45528
Wang S., Yang Y., Li S., Chen H., Zhao Y., & Mu J. (2022). Recent advances in macrophage-derived exosomes as delivery vehicles. Nano TransMed, 1 (2–4), e9130013. https://doi.org/10.26599/NTM.2022.9130013
Liu B., Nguyen P. L., Yu H., Li X., Wang H., Price J., Niu M., Guda C., Cheng X., Sun X., Moreau R., Ramer-Tait A., Naldrett M. J., Alvarez S., & Yu J. (2023). Critical contributions of protein cargos to the functions of macrophage-derived extracellular vesicles. Journal of Nanobiotechnology, 21 (1), 352. https://doi.org/10.1186/s12951-023-02105-9
Savchenko I. V., Zlotnikov I. D., & Kudryashova E. V. (2023). Biomimetic Systems Involving Macrophages and Their Potential for Targeted Drug Delivery. Biomimetics, 8 (7), 543. https://doi.org/10.3390/biomimetics8070543
Kim M. S., Haney M. J., Zhao Y., Mahajan V., Deygen I., Klyachko N. L., Inskoe E., Piroyan A., Sokolsky M., Okolie O., Hingtgen S. D., Kabanov A. V., & Batrakova E. V. (2016). Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine: Nanotechnology, Biology and Medicine, 12 (3), 655 664. https://doi.org/10.1016/j.nano.2015.10.012
Gao C., Huang Q., Liu C., Kwong C. H. T., Yue L., Wan J.-B., Lee S. M. Y., & Wang R. (2020). Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines. Nature Communications, 11 (1), 2622. https://doi.org/10.1038/s41467-020-16439-7
Neupane K. R., McCorkle J. R., Kopper T. J., Lakes J. E., Aryal S. P., Abdullah M., Snell A. A., Gensel J. C., Kolesar J., & Richards C. I. (2021). Macrophage-Engineered Vesicles for Therapeutic Delivery and Bidirectional Reprogramming of Immune Cell Polarization. ACS Omega, 6 (5), 3847 3857. https://doi.org/10.1021/acsomega.0c05632
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista de divulgación científica iBIO
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Self-archiving or deposit of the works in their post-publication version (editorial version) is permitted in any personal, institutional or thematic repository, social or scientific networks. The above applies from the moment of publication of the article in question on the website of the Revista de divulgación científica iBIO.
